α-Methylacyl-CoA Racemase: Expression Levels of this Novel Cancer Biomarker Depend on Tumor Differentiation

[1]  M. Rubin,et al.  Alpha-Methylacyl-CoA Racemase: A Novel Tumor Marker Over-expressed in Several Human Cancers and Their Precursor Lesions , 2002, The American journal of surgical pathology.

[2]  J. Trent,et al.  α-methylacyl-CoA racemase: A new molecular marker for prostate cancer , 2002 .

[3]  Debashis Ghosh,et al.  alpha-Methylacyl coenzyme A racemase as a tissue biomarker for prostate cancer. , 2002, JAMA.

[4]  J. Trent,et al.  Alpha-methylacyl-CoA racemase: a new molecular marker for prostate cancer. , 2002, Cancer research.

[5]  Kathleen R. Cho,et al.  Loss of CDX2 expression and microsatellite instability are prominent features of large cell minimally differentiated carcinomas of the colon. , 2001, The American journal of pathology.

[6]  T. Stamey,et al.  Molecular genetic profiling of Gleason grade 4/5 prostate cancers compared to benign prostatic hyperplasia. , 2001, The Journal of urology.

[7]  S. Reed,et al.  P504S: A New Molecular Marker for the Detection of Prostate Carcinoma , 2001, The American journal of surgical pathology.

[8]  M. Rubin,et al.  Relational database structure to manage high-density tissue microarray data and images for pathology studies focusing on clinical outcome: the prostate specialized program of research excellence model. , 2001, The American journal of pathology.

[9]  M. Moyad.  Fat reduction to prevent prostate cancer: waiting for more evidence? , 2001, Current opinion in urology.

[10]  S. Dhanasekaran,et al.  Delineation of prognostic biomarkers in prostate cancer , 2001, Nature.

[11]  J. Welsh,et al.  Analysis of gene expression identifies candidate markers and pharmacological targets in prostate cancer. , 2001, Cancer research.

[12]  A. Partin,et al.  Long-term biochemical disease-free and cancer-specific survival following anatomic radical retropubic prostatectomy. The 15-year Johns Hopkins experience. , 2001, The Urologic clinics of North America.

[13]  Jeffrey A. Magee,et al.  Expression profiling reveals hepsin overexpression in prostate cancer. , 2001, Cancer research.

[14]  M. Bittner,et al.  Human prostate cancer and benign prostatic hyperplasia: molecular dissection by gene expression profiling. , 2001, Cancer research.

[15]  P. Vreken,et al.  Plasma analysis of di- and trihydroxycholestanoic acid diastereoisomers in peroxisomal alpha-methylacyl-CoA racemase deficiency. , 2001, Journal of lipid research.

[16]  S. Ferdinandusse,et al.  Subcellular localization and physiological role of alpha-methylacyl-CoA racemase. , 2000, Journal of lipid research.

[17]  Kris Eb,et al.  Deciding on radiation therapy for prostate cancer: the physician's perspective. , 2000 .

[18]  J. Hiltunen,et al.  In Mouse α-Methylacyl-CoA Racemase, the Same Gene Product Is Simultaneously Located in Mitochondria and Peroxisomes* , 2000, The Journal of Biological Chemistry.

[19]  M. Resnick,et al.  Analysis of recent trends in prostate cancer incidence and mortality , 2000, The Prostate.

[20]  K. Pienta,et al.  Rapid ("warm") autopsy study for procurement of metastatic prostate cancer. , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.

[21]  C. Koprowski,et al.  Deciding on radiation therapy for prostate cancer: the physician's perspective. , 2000, Seminars in urologic oncology.

[22]  H. Bartsch,et al.  Dietary polyunsaturated fatty acids and cancers of the breast and colorectum: emerging evidence for their role as risk modifiers. , 1999, Carcinogenesis.

[23]  E. Feuer,et al.  Cancer surveillance series: interpreting trends in prostate cancer--part III: Quantifying the link between population prostate-specific antigen testing and recent declines in prostate cancer mortality. , 1999, Journal of the National Cancer Institute.

[24]  T. Tammela,et al.  European randomized study of prostate cancer screening: first-year results of the Finnish trial , 1999, British Journal of Cancer.

[25]  P. J. van der Maas,et al.  Evaluation of the digital rectal examination as a screening test for prostate cancer. Rotterdam section of the European Randomized Study of Screening for Prostate Cancer. , 1999, Journal of the National Cancer Institute.

[26]  Fritz H. Schröder,et al.  Evaluation of the Digital Rectal Examination as a Screening Test for Prostate Cancer , 1998 .

[27]  J. Altwein.  Therapeutic Options in Locally Defined or Advanced Prostate Cancer , 1998, European Urology.

[28]  M. Webber,et al.  Androgen responsive adult human prostatic epithelial cell lines immortalized by human papillomavirus 18. , 1997, Carcinogenesis.

[29]  R. Fingerhut,et al.  Purification and characterization of an alpha-methylacyl-CoA racemase from human liver. , 1995, European journal of biochemistry.

[30]  L. Cohen.  Diet and cancer , 1993, Nature.

[31]  F W MULSOW,et al.  Cancer incidence and mortality , 2019, Health at a Glance: Europe.